09
November
2015
|
00:00
Europe/Amsterdam

BIOTRONIK Affirms Commitment to Physician Education at Forum Featuring World Leading Electrophysiologists

Global Symposium on Advanced Concepts in Electrophysiology receives support from one of the globe’s leading cardiovascular medical technology manufacturers

LAKE OSWEGO, Oregon, Nov. 9, 2015 – BIOTRONIK, Inc. continues its support of the Advanced Concepts in Electrophysiology (ACE), an educational program for electrophysiologists and device-oriented cardiologists, with the largest gathering this year in the program’s history. Hosting more than 150 specialists in cardiac rhythm management, the 2015 ACE program ‑- held for the sixth consecutive year at NYU Langone Medical Center ‑- underscores the draw of top-tier global medical education.

Course content included a blend of didactic sessions and live cases which spanned the breadth of clinical cardiac electrophysiology ‑- including atrial fibrillation, cardiac resynchronization therapy and diagnosis of complex arrhythmias ‑- in a forum designed to maximize interaction between esteemed faculty and physician participants. Live cases included ventricular and atrial tachycardia ablations, as well as implants of the latest cardiac rhythm therapy device technology.

“This unique educational program focuses on the latest advances in cardiac therapy and technology and features an internationally acclaimed faculty, whose many works and scientific contributions have helped shape the field of clinical cardiac electrophysiology,” said Larry A. Chinitz, MD, Benjamin and Coyle Family Professor of Medicine and Course Director of the educational program. “This global symposium enables us to offer a robust agenda that focuses on educating leaders in the field about the application of cutting-edge technologies and patient management strategies.”

“More than 150 physicians from around the world who specialize in treating patients with heart rhythm disorders are participating in this important scientific collaboration between BIOTRONIK and a premier thought-leader faculty,” said Patrick Newton, Vice President, Medical and Academic Affairs at BIOTRONIK, Inc. “This collaboration is a prime example of BIOTRONIK's commitment to world-class physician education and training that begins with the International Fellows Program and extends to physicians following their transition to practice or academic medicine.”

  1. Investigational device: Limited by United States law to investigational use.

About BIOTRONIK:

BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.